Efficacy and Safety of Postoperative Concurrent Chemoradiotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma: A Multicenter Prospective Phase II Study

NCT07636824 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Interventions

RADIATION: Postoperative radiotherapy
DRUG: Capecitabine or S-1

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences